Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02092428 · ClinicalTrials.gov registry record · Phase 1
Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)
A Phase 1 study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 333
- Enrollment target
NCT02092428: Completed Phase 1 study, sponsored by Cedars-Sinai Medical Center.
NCT02092428 is a Phase 1 study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 333 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (455% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02092428, a Phase 1 study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 333 participants
- Enrollment target
Study Summary
Investigators at the Biomedical Imaging Research Institute (BIRI) at Cedars-Sinai Medical Center have developed a Magnetic Resonance Imaging (MRI) method for imaging coronary arteries using slow-infusion, contrast-enhanced data acquisition. This method allows faster data acquisition and better spatial resolution. Specific aims of this study are to: 1. compare coronary artery imaging with and without contrast media on both healthy subjects and patients; 2. assess the accuracy of coronary MRI in detecting coronary artery disease as compared to conventional x-ray angiography Researchers hypothesize that contrast-enhanced MRI will improve the delineation of coronary arteries over non-contrast-enhanced MRI and that optimized, contrast-enhanced coronary MRI technique will accurately detect coronary artery disease (CAD) as compared to conventional x-ray angiography.
Primary Outcome
sensitivity and specificity
Interventions
- OTHER Image Quality
- OTHER Diagnostic Accuracy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2011-04 |
| Est. Completion | 2017-03-01 |
| Phase | Phase 1 |
What the finished NCT02092428 record still lists
NCT02092428 is an interventional study that assigns participants to a tested intervention. The registered 333 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (455% higher).
The record links to 0 conditions, and to 2 interventions - of which Image Quality is the first listed.
NCT02092428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02092428 about?
NCT02092428 is a clinical study titled "Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)". Investigators at the Biomedical Imaging Research Institute (BIRI) at Cedars-Sinai Medical Center have developed a Magnetic Resonance Imaging (MRI) method for imaging coronary arteries using slow-infusion, contrast-enhanced data acquisition. This method allows faster data acquisition and better spati...
What is the current status of trial NCT02092428?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 333 participants. The study started on 2011-04. Estimated completion is 2017-03-01.
What interventions are being tested in trial NCT02092428?
The interventions under investigation include: Image Quality (OTHER), Diagnostic Accuracy (OTHER).
Who is sponsoring clinical trial NCT02092428?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02092428's enrollment target sits among peer trials
333 108th of 2000 higher than 1,893 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07395687 · 333 participants · Phase 2
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
- NCT05131672 · 334 participants · NA
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
- NCT05131685 · 334 participants · NA
Distal Radius Interventions for Fracture Treatment
- NCT05546931 · 334 participants · NA
Mobile Health Program for Rural Hypertension
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia